Sirona Biochem (Germany) Today
| ZSB Stock | EUR 0.04 0.00 0.00% |
PerformanceVery Weak
| Odds Of DistressLow
|
Sirona Biochem is trading at 0.036 as of the 19th of July 2025. This is a No Change since the beginning of the trading day. The stock's lowest day price was 0.036. Sirona Biochem has about a 23 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 20th of April 2025 and ending today, the 19th of July 2025. Click here to learn more.
Sirona Biochem Corp. operates as a cosmetic ingredient and drug discovery company in Canada and France. Sirona Biochem Corp. was incorporated in 2006 and is headquartered in Vancouver, Canada. SIRONA BIOCHEM operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange.. The company has 251.73 M outstanding shares. More on Sirona Biochem Corp
Sirona Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Sirona Biochem's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Sirona Biochem or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Thematic Idea | Iron (View all Themes) |
| Business Concentration | Iron, Biotechnology, Healthcare (View all Sectors) |
Sirona Biochem Corp (ZSB) is traded on Frankfurt Exchange in Germany and employs 4 people. The company currently falls under 'Micro-Cap' category with a current market capitalization of 17.51 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Sirona Biochem's market, we take the total number of its shares issued and multiply it by Sirona Biochem's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Sirona Biochem Corp classifies itself under Healthcare sector and is part of Biotechnology industry. The entity has 251.73 M outstanding shares.
Sirona Biochem Corp has accumulated about 120.26 K in cash with (2.16 M) of positive cash flow from operations.
Check Sirona Biochem Probability Of Bankruptcy
Ownership AllocationSirona Biochem Corp shows a total of 251.73 Million outstanding shares. Sirona Biochem Corp has 10.43 % of its outstanding shares held by insiders and 0.0 % owned by institutional holders. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Sirona Ownership Details
Sirona Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Sirona Biochem without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Earnings Calls Now
Earnings CallsCheck upcoming earnings announcements updated hourly across public exchanges |
| All Next | Launch Module |
Sirona Biochem Corporate Management
Elected by the shareholders, the Sirona Biochem's board of directors comprises two types of representatives: Sirona Biochem inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sirona. The board's role is to monitor Sirona Biochem's management team and ensure that shareholders' interests are well served. Sirona Biochem's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sirona Biochem's outside directors are responsible for providing unbiased perspectives on the board's policies.
| CPA CGA | CFO Director | Profile | |
| Graldine DeliencourtGodefroy | Chief Director | Profile | |
| Michelle MBA | VP Operations | Profile | |
| Brett Premack | Scientific Consultant | Profile |
Other Information on Investing in Sirona Stock
Sirona Biochem financial ratios help investors to determine whether Sirona Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sirona with respect to the benefits of owning Sirona Biochem security.